A Placebo-Controlled, Single-Blind, Single-Ascending Dose Study With Additional Multiple-Ascending Dose Cohorts to Evaluate the Safety, Tolerability, and Pharmacokinetics of TKM-100802 in Healthy Human Volunteers

Trial Profile

A Placebo-Controlled, Single-Blind, Single-Ascending Dose Study With Additional Multiple-Ascending Dose Cohorts to Evaluate the Safety, Tolerability, and Pharmacokinetics of TKM-100802 in Healthy Human Volunteers

Discontinued
Phase of Trial: Phase I

Latest Information Update: 26 Nov 2015

At a glance

  • Drugs TKM Ebola (Primary)
  • Indications Ebola virus infections
  • Focus Adverse reactions
  • Sponsors Arbutus Biopharma
  • Most Recent Events

    • 06 Aug 2015 Status changed from recruiting to discontinued, as reported by ClinicalTrials.gov.
    • 28 May 2015 Planned number of patients changed from 28 to 20 as reported by ClinicalTrials.gov
    • 28 May 2015 Planned End Date changed from 1 Jul 2014 to 1 Jul 2015 as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top